Development of a Multi-attribute Health Index to Measure the Quality of Labour Analgesia: Psychometric Development of a Quality of Neuraxial Labour Analgesia Scale
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The current lack of a tool to measure the overall quality of neuraxial pain relief provided in labour analgesia trials has produced studies unable to provide clear direction to clinical care and research. Our previous work explored and described the underlying dimensions and attributes of quality neuraxial analgesia from the perspectives of labouring women as the initial phase of development of an Index to measure this as an outcome in research. We now seek to confirm our findings as well as to generate additional items (descriptors) of quality neuraxial analgesia from the perspectives of parturients and experts (obstetrical anesthesiologists and experienced labour nurses). Once generated, the full list of items will be used to in a subsequent study involving only parturients (Item Reduction phase) to develop a scale permitting global measurement of quality neuraxial labour analgesia. The resulting scale, once validated, will provide researchers with a simple global measure for quality in labour analgesia research. This scale will be used later in our program of research to assist with validation studies of the larger Multi-attribute Health Index we are developing.
| Condition |
|---|
|
Labour Pain |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
Eligibility| Ages Eligible for Study: | 18 Years to 60 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Women who received neuraxial labour analgesia during the current pregnancy
Inclusion Criteria:
- Use of neuraxial labour analgesia during the current pregnancy
- Native English-speakers
- Term pregnancies (>37-42weeks)
- The ability to read and write in English
- Provision of written informed consent.
Exclusion Criteria:
- Women who received IM or IV narcotics within 4 hours of epidural/ combined spinal epidural (CSE) placement
- Women with evidence or history of maternal cognitive impairment
- Women who experienced a neonatal death during the current pregnancy
Contacts and Locations| Canada, Ontario | |
| Sunnybrook Health Sciences Centre | Recruiting |
| Toronto, Ontario, Canada | |
| Contact: Dr. Pamela Angle, MD, MSc 416-323-6400 ext 6269 | |
| Principal Investigator: | Dr. Pamela Angle, MD, MSc | Sunnybrook Health Sciences Centre |
More Information
No publications provided
| Responsible Party: | Dr. Pamela Angle, Sunnybrook Health Sciences Centre |
| ClinicalTrials.gov Identifier: | NCT01177046 History of Changes |
| Other Study ID Numbers: | 160-2002 |
| Study First Received: | August 4, 2010 |
| Last Updated: | July 27, 2011 |
| Health Authority: | Canada: Ethics Review Committee |
Keywords provided by Sunnybrook Health Sciences Centre:
|
Women receiving a labour epidural during most recent delivery |
Additional relevant MeSH terms:
|
Labor Pain Pain Neurologic Manifestations Nervous System Diseases Signs and Symptoms |
ClinicalTrials.gov processed this record on June 18, 2013